Checked
Class IIDrug recallOngoing
Naproxen Tablets recall
Recalled by Glenmark Pharmaceuticals Inc., USA of Mahwah, NJ · FDA report 12/06/2023
Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.
- Class
- Class II
- Moderate
- Status
- Ongoing
- Recall started
- 11/07/2023
- Distribution
- Nationwide
Reason for recall
Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Recalled product
- Product
- Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-188-01.
- Lot and code info
- Lot# 19231903; Exp 4/2025 Lot# 19231858; Exp 4/2025 Lot# 19231881; Exp 4/2025 Lot# 19233484: Exp 8/2025 Lot# 19233490; Exp 8/2025
- Brand names
- NAPROXEN SODIUM
- Recall number
- D-0124-2024
- Event ID
- 93368
- Initiated by
- Voluntary: Firm initiated
Where it was distributed
Nationwide
- Nationwide
Recall timeline
- 11/07/2023Firm started the recall
- 11/27/2023FDA classified it as Class II
- 12/06/2023Published in the FDA enforcement report
All products in this recall
2 products under event 93368
- D-0123-2024Indomethacin 25mg Capsules, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured...
- D-0124-2024Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured for... This page
More recalls from Glenmark Pharmaceuticals Inc., USA
- Class IIDrugOngoing08/05/2026Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark...Glenmark Pharmaceuticals Inc., USA · CGMP Deviations: Product quality complaints concerning abnormal...
- Class IIDrugOngoing06/24/2026Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1...Glenmark Pharmaceuticals Inc., USA · Failed Impurities/Degradation Specifications: This recall is being...
- Class IIDrugOngoing01/07/2026Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10...Glenmark Pharmaceuticals Inc., USA · Defective container: Preferred Pharmaceuticals received a letter...
- Class IIIDrugOngoing12/17/2025Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited...Glenmark Pharmaceuticals Inc., USA · Cross Contamination with Other Products
- Class IIIDrugOngoing12/10/2025Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count...Glenmark Pharmaceuticals Inc., USA · Cross Contamination with Other Products: Testing of reserve...
- Class IIDrugOngoing10/22/2025Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01...Glenmark Pharmaceuticals Inc., USA · Failed Impurities/Degradation Specifications
Frequently asked questions
- Why was Naproxen Tablets recalled?
- Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
- What does Class II mean?
- Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
- Where was the recalled product sold?
- Nationwide
- Is this recall still active?
- The FDA lists the recall as ongoing. The recall is still in progress.
Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 12/06/2023 · Do not rely on openFDA to make decisions regarding medical care